Clinical Trial Update: Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 study of LAPS-Exendin in adults with Type 2 Diabetes Mellitus has completed. The study evaluated safety, tolerability, pharmacokinetics, and pharmacodyn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LAPS-Exendin

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED